US20050186353A1 - Method for making a porous calcium phosphate article - Google Patents
Method for making a porous calcium phosphate article Download PDFInfo
- Publication number
- US20050186353A1 US20050186353A1 US11/071,631 US7163105A US2005186353A1 US 20050186353 A1 US20050186353 A1 US 20050186353A1 US 7163105 A US7163105 A US 7163105A US 2005186353 A1 US2005186353 A1 US 2005186353A1
- Authority
- US
- United States
- Prior art keywords
- phosphate
- calcium
- acid
- calcium phosphate
- article
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
- A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/34—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
- C04B35/447—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on phosphates, e.g. hydroxyapatite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B38/00—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
- C04B38/02—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by adding chemical blowing agents
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3205—Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
- C04B2235/3208—Calcium oxide or oxide-forming salts thereof, e.g. lime
Definitions
- the present invention is related to a porous calcium phosphate article for use as a medical implant, and in particular to a method of making a porous calcium phosphate scaffold for use as tissue-engineered scaffold.
- a tissue-engineered scaffold (majority made from biodegradable polymers) has a very porous structure that allows living cells (usually taken from the patient being treated) to penetrate into the structure and be “seeded” in-vitro during a cell culture process.
- the cell-seeded scaffold is implanted into either an animal (e.g., rat) whose immune system has been removed, or into the patient himself (usually under the skin for easier later-on process).
- the cells quickly multiply from absorbing nutrients from the animal or the patient's body, and, at the same time, the scaffold itself is gradually dissolved or resorbed.
- tissue-engineered scaffold U.S. Pat. No. 6,139,578; U.S. Pat. No. 6,200,606; U.S. Pat. No. 5,306,303; and U.S. Pat. No. 6,132,463.
- a tissue-engineered scaffold is bioresorbable, sufficiently porous and supportive at the same time.
- the conventional high temperature (usually >1000° C.)-sintered porous hydroxyapatite (HA) block material does not possess sufficient micro/nano-sized porosity and is hardly bioresorbable.
- the conventional biodegradable polymer for scaffold application exhibits a relatively low strength and too high a dissolution rate.
- a primary objective of the invention is to provide a porous calcium phosphate article or block for use as a tissue-engineered scaffold, which is free from the aforesaid drawbacks in the prior art, or as a functional implant other than the tissue-engineered scaffold.
- This objective is accomplished by providing a novel method for making a porous calcium phosphate article, which involves a) preparing a shaped article from a paste comprising a calcium phosphate cement, a pore-forming powder and a setting liquid; and b) immersing said shaped article in an immersing liquid for a period of time so that said pore-forming powder is dissolved in the immersing liquid, creating pores in said shaped article.
- the preferred embodiments of the present invention include (but not limited thereto):
- a method for making a porous calcium phosphate article comprising:
- said pore-forming powder is selected from the group consisting of LiCl, KCl, NaCl, MgCl 2 , CaCl 2 , NaIO 3 , KINa 3 , PO 4 , K 3 PO 4 , Na 2 CO 3 , amino acid-sodium salt, amino acid-potassium salt, glucose, polysaccharide, fatty acid-sodium salt, fatty acid-potassium salt, potassium bitartrate (KHC 4 H 4 O 6 ), potassium carbonate, potassium gluconate (KC 6 H 11 O 7 ), potassium-sodium tartrate (KNaC 4 H 4 O 6 .4H 2 O), potassium sulfate (K 2 SO 4 ), sodium sulfate, and sodium lactate.
- said pore-forming powder is selected from the group consisting of LiCl, KCl, NaCl, MgCl 2 , CaCl 2 , NaIO 3 , KINa 3 , PO 4 , K 3 PO 4 , Na 2 CO
- the immersing liquid is an acidic aqueous solution, a basic aqueous solution, a physiological solution, an organic solvent, or a substantially pure water.
- the impregnating liquid is an acidic solution, a basic solution, a physiological solution, or a substantially pure water.
- step ii) and iv) is carried out at room temperature or at a temperature between about 30 and 90° C.
- step i) comprises the following steps:
- said calcium phosphate source in step (a) comprises one or more calcium phosphates selected from the group consisting of alpha-tricalcium phosphate ( ⁇ -TCP), beta-tricalcium phosphate ( ⁇ -TCP), tetracalcium phosphate (TTCP), monocalcium phosphate monohydrate (MCPM), monocalcium phosphate anhydrous (MCPA), dicalcium phosphate dihydrate (DCPD), dicalcium phosphate anhydrous (DCPA), octacalcium phosphate (OCP), calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium phosphate tribasic, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, and amorphous calcium phosphate.
- ⁇ -TCP alpha-tricalcium phosphate
- step (a) is tetracalcium phosphate (TTCP).
- TTCP tetracalcium phosphate
- the calcium phosphate source comprises at least one calcium phosphate particle having calcium phosphate whiskers on the surface of said calcium phosphate particle, wherein said calcium phosphate whiskers have a length of about 1-5000 nm and a width of about 1-500 nm.
- step (b) is an acidic solution, a basic solution, or substantially pure water.
- said acidic solution is selected from the group consisting of nitric acid (HNO 3 ), hydrochloric acid (HCl), phosphoric acid (H 3 PO 4 ), carbonic acid (H 2 CO 3 ), sodium dihydrogen phosphate (NaH 2 PO 4 ), sodium dihydrogen phosphate monohydrate (NaH 2 PO 4 .H 2 O), sodium dihydrogen phosphate dihydrate, sodium dihydrogen phosphate dehydrate, potassium dihydrogen phosphate (KH 2 PO 4 ), ammonium dihydrogen.phosphate (NH 4 H 2 PO 4 ), malic acid, acetic acid, lactic acid, citric acid, malonic acid, succinic acid, glutaric acid, tartaric acid, oxalic acid and their mixture.
- HNO 3 nitric acid
- HCl hydrochloric acid
- H 3 PO 4 phosphoric acid
- carbonic acid H 2 CO 3
- sodium dihydrogen phosphate NaH 2 PO 4
- sodium dihydrogen phosphate monohydrate
- said basic solution is selected from the group consisting of ammonia, ammonium hydroxide, alkali metal hydroxide, alkali earth hydroxide, disodium hydrogen phosphate (Na 2 HPO 4 ), disodium hydrogen phosphate dodecahydrate, disodium hydrogen phosphate heptahydrate, sodium phosphate dodecahydrate (Na 3 PO 4 .12H 2 O), dipotassium hydrogen phosphate (K 2 HPO 4 ), potassium hydrogen phosphate trihydrate (K 2 HPO 4 .3H 2 O), potassium phosphate tribasic (K 3 PO 4 ), diammonium hydrogen phosphate ((NH 4 ) 2 HPO 4 ), ammonium phosphate trihydrate ((NH 4 ) 3 PO 4 .3H 2 O), sodium hydrogen carbonate (NaHCO 3 ), sodium carbonate Na 2 CO 3 , and their mixture.
- said basic solution is selected from the group consisting of ammonia, ammonium hydroxide, alkali metal hydroxide, alkali
- step (c) further comprises removing a portion of liquid from said paste, so that a liquid/powder ratio of said paste decreases.
- step (c) further comprises pressurizing said paste in said mold before said hardening reaction is complete to remove a portion of liquid from said paste, so that a liquid/powder ratio of said paste decreases.
- step (c) further comprises heating said paste during said pressurizing.
- step (c) further comprises heating said paste during molding.
- the method according to item 30 further comprising heating the resulting cleaned and dried porous shaped article.
- porous shaped calcium phosphate article made according to the method of the present invention may be used as a tissue-engineered scaffold, medical implant or a reinforcing constituent of a composite.
- a Ca 4 (PO 4 ) 2 O (TTCP) powder was prepared by mixing Ca 2 P 2 O 7 powder with CaCO 3 powder uniformly in ethanol for 24 hours followed by heating to dry.
- the mixing ratio of Ca 2 P 2 O 7 powder to CaCO 3 powder was 1:1.27 (weight ratio) and the powder mixture was heated to 1400° C. to allow two powders to react to form TTCP.
- the TTCP powder prepared according to the method of PREPARATIVE EXAMPLE 1 was sieved and blended with dried CaHPO 4 (DCPA) powder in a ball mill for 12 hours.
- the blending ratio of the TTCP powder to the DCPA powder was 1:1 (molar ratio).
- the resultant powder mixture was added to a 25 mM diluted solution of phosphate to obtain a powder/solution mixture having a concentration of 3 g powder mixture per 1 ml solution while stirring.
- the resulting powder/solution mixture was formed into pellets, and the pellets were heated in an oven at 50° C. for 10 minutes.
- the pellets were then uniformly ground in a mechanical mill for 20 minutes to obtain the non-dispersive TTCP/DCPA-based CPC powder (ND-CPC).
- the particles of this ND-CPC powder have whiskers on the surfaces thereof.
- the compressed CPC block was immersed in a deionized water at 37° C. for 4 day, 8 days, and 16 days.
- the compressive strength of the specimens of the three different periods of immersion time was measured by using a AGS-500D mechanical tester (Shimadzu Co., Ltd., Kyoto, Japan) after the specimens were dry.
- the measured dry specimen compressive strength is listed Table 1.
- the optimal conditions for the heat treatment is 400° C. for two hours, thereby the dry compressive strength of the porous CPC block was increased from 1.7 to 2.7 MPa.
- Na 2 CO 3 was used as the pore-forming powder in the preparation of the porous CPC blocks, which had the dry compressive strength and the porosity comparable to those disclosed in Examples 1-9.
Abstract
The present invention discloses a method for making a porous calcium phosphate article including i) preparing a shaped article from a paste containing a calcium phosphate cement, a pore-forming powder and a setting liquid; ii) immersing the shaped article in an immersing liquid for a period of time so that the pore-forming powder is dissolved in the immersing liquid, creating pores in said shaped article; and iii) removing the resulting porous shaped article from the immersing liquid, wherein the resulting porous shaped article has an improved compressive strength. The porous shaped calcium phosphate article of the present invention may be used as a tissue-engineered scaffold, medical implant or a reinforcing constituent of a composite.
Description
- This application is a continuation of co-pending U.S. patent application Ser. No. 10/780,728 entitled “METHOD FOR MAKING A POROUS CALCIUM PHOSPHATE ARTICLE” filed on Feb. 19, 2004, herein incorporated by reference.
- 1. Field of the Invention
- The present invention is related to a porous calcium phosphate article for use as a medical implant, and in particular to a method of making a porous calcium phosphate scaffold for use as tissue-engineered scaffold.
- 2. Description of the Related Art
- A tissue-engineered scaffold (majority made from biodegradable polymers) has a very porous structure that allows living cells (usually taken from the patient being treated) to penetrate into the structure and be “seeded” in-vitro during a cell culture process. After a period of time (days or weeks) of cell culture, the cell-seeded scaffold is implanted into either an animal (e.g., rat) whose immune system has been removed, or into the patient himself (usually under the skin for easier later-on process). During this period of time (weeks to months) the cells quickly multiply from absorbing nutrients from the animal or the patient's body, and, at the same time, the scaffold itself is gradually dissolved or resorbed. When this process is substantially “mature”, the implant (now a real bone) is removed from under the skin of the animal or the patient and re-implanted into the (wounded or diseased) site being treated. The following are some references describing some details about the background, requirements, applications, etc. of tissue-engineered scaffold: U.S. Pat. No. 6,139,578; U.S. Pat. No. 6,200,606; U.S. Pat. No. 5,306,303; and U.S. Pat. No. 6,132,463.
- It is advantageous if a tissue-engineered scaffold is bioresorbable, sufficiently porous and supportive at the same time. The conventional high temperature (usually >1000° C.)-sintered porous hydroxyapatite (HA) block material does not possess sufficient micro/nano-sized porosity and is hardly bioresorbable. On the other hand, the conventional biodegradable polymer for scaffold application exhibits a relatively low strength and too high a dissolution rate.
- A primary objective of the invention is to provide a porous calcium phosphate article or block for use as a tissue-engineered scaffold, which is free from the aforesaid drawbacks in the prior art, or as a functional implant other than the tissue-engineered scaffold.
- This objective is accomplished by providing a novel method for making a porous calcium phosphate article, which involves a) preparing a shaped article from a paste comprising a calcium phosphate cement, a pore-forming powder and a setting liquid; and b) immersing said shaped article in an immersing liquid for a period of time so that said pore-forming powder is dissolved in the immersing liquid, creating pores in said shaped article.
- Features and advantages of the present invention are as follows:
-
- 1. The porous calcium phosphate article made according to the present invention can transform into an apatite-dominated material shortly after immersion in physiological solution or after implantation.
- 2. The porous calcium phosphate block made according to the present invention exhibits a higher strength than most other bioactive or biodegradable porous blocks with a similar porosity level.
- 3. The calcium phosphate block made according to the present invention possesses a significant amount of micro- and nano-sized porosity, that improves bioresorbability thereof.
- The preferred embodiments of the present invention include (but not limited thereto):
- 1. A method for making a porous calcium phosphate article comprising:
-
- i) preparing a shaped article from a paste comprising a calcium phosphate cement, a pore-forming powder and a setting liquid;
- ii) ii) immersing said shaped article in an immersing liquid for a first period of time so that said pore-forming powder is dissolved in the immersing liquid, creating pores in said shaped article;
- iii) removing the resulting porous shaped article from said immersing liquid; and
- iv) immersing the porous shaped article from step iii) in an impregnating liquid for a second period of time so that a compressive strength of the resulting article removed from the impregnating liquid is increased compared to that of said porous shaped article without said impregnating treatment,
- v) wherein step iii) is omitted and a compressive strength of the resulting porous shaped article removed from the immersing liquid after the first and the second periods of time is increased compared to that of the resulting porous shaped article removed after the first period of time, when the immersing liquid and the impregnating liquid are the same.
- 2. The method according to item 1, wherein said pore-forming powder is selected from the group consisting of LiCl, KCl, NaCl, MgCl2, CaCl2, NaIO3, KINa3, PO4, K3PO4, Na2CO3, amino acid-sodium salt, amino acid-potassium salt, glucose, polysaccharide, fatty acid-sodium salt, fatty acid-potassium salt, potassium bitartrate (KHC4H4O6), potassium carbonate, potassium gluconate (KC6H11O7), potassium-sodium tartrate (KNaC4H4O6.4H2O), potassium sulfate (K2SO4), sodium sulfate, and sodium lactate.
- 3. The method according to item 1, wherein the immersing liquid is an acidic aqueous solution, a basic aqueous solution, a physiological solution, an organic solvent, or a substantially pure water.
- 3. The method according to item 3, wherein the immersing liquid comprises at least one of Ca and P sources.
- 5. The method according to item 3, wherein the immersing liquid is a Hanks' solution, a HCl aqueous solution or an aqueous solution of (NH4)2HPO4.
- 6. The method according to item 3, wherein the immersing liquid and the impregnating liquid are the same.
- 7. The method according to item 4, wherein the immersing liquid and the impregnating liquid are the same.
- 8. The method according to item 5, wherein the immersing liquid and the impregnating liquid are the same.
- 9. The method according to item 1, wherein the immersing liquid and the impregnating liquid are different.
- 10. The method according to item 9, wherein the impregnating liquid is an acidic solution, a basic solution, a physiological solution, or a substantially pure water.
- 11. The method according to item 10, wherein the impregnating liquid comprises at least one of Ca and P sources.
- 12. The method according to item 10, wherein the impregnating liquid is a Hanks' solution, a HCl aqueous solution or an aqueous solution of (NH4)2HPO4.
- 13. The method according to item 1, wherein the first period of time is longer than 10 minutes.
- 14. The method according to item 13, wherein the first period of time is longer than 1 day.
- 15. The method according to item 1, wherein the second period of time is longer than 10 minutes.
- 16. The method according to item 15, wherein the second period of time is longer than 1 day.
- 17. The method according to item 1, wherein the immersing in step ii) and iv) is carried out at room temperature or at a temperature between about 30 and 90° C.
- 18. The method according to item 1, wherein said preparing of step i) comprises the following steps:
- (a) preparing a first powder as said calcium phosphate cement comprising at least one Ca source and at least one P source, or at least one calcium phosphate source;
- (b) mixing said first powder and the pore-forming powder with said setting liquid to form said paste, wherein said first powder and said setting liquid undergo a hardening reaction;
- (c) molding said paste into an article in a mold of a desired shape and size before said hardening reaction is complete; and
- (d) removing said molded article from said mold.
- 19. The method according to item 18, wherein said calcium phosphate source in step (a) comprises one or more calcium phosphates selected from the group consisting of alpha-tricalcium phosphate (α-TCP), beta-tricalcium phosphate (β-TCP), tetracalcium phosphate (TTCP), monocalcium phosphate monohydrate (MCPM), monocalcium phosphate anhydrous (MCPA), dicalcium phosphate dihydrate (DCPD), dicalcium phosphate anhydrous (DCPA), octacalcium phosphate (OCP), calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium phosphate tribasic, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, and amorphous calcium phosphate.
- 20. The method according to item 19, wherein said calcium phosphate source in step (a) is tetracalcium phosphate (TTCP).
- 21. The method according to item 19, wherein the calcium phosphate source comprises at least one calcium phosphate particle having calcium phosphate whiskers on the surface of said calcium phosphate particle, wherein said calcium phosphate whiskers have a length of about 1-5000 nm and a width of about 1-500 nm.
- 22. The method according to item 19, wherein the setting liquid in step (b) is an acidic solution, a basic solution, or substantially pure water.
- 23. The method according to item 22, wherein said acidic solution is selected from the group consisting of nitric acid (HNO3), hydrochloric acid (HCl), phosphoric acid (H3PO4), carbonic acid (H2CO3), sodium dihydrogen phosphate (NaH2PO4), sodium dihydrogen phosphate monohydrate (NaH2PO4.H2O), sodium dihydrogen phosphate dihydrate, sodium dihydrogen phosphate dehydrate, potassium dihydrogen phosphate (KH2PO4), ammonium dihydrogen.phosphate (NH4H2PO4), malic acid, acetic acid, lactic acid, citric acid, malonic acid, succinic acid, glutaric acid, tartaric acid, oxalic acid and their mixture.
- 24. The method according to item 22, wherein said basic solution is selected from the group consisting of ammonia, ammonium hydroxide, alkali metal hydroxide, alkali earth hydroxide, disodium hydrogen phosphate (Na2HPO4), disodium hydrogen phosphate dodecahydrate, disodium hydrogen phosphate heptahydrate, sodium phosphate dodecahydrate (Na3PO4.12H2O), dipotassium hydrogen phosphate (K2HPO4), potassium hydrogen phosphate trihydrate (K2HPO4.3H2O), potassium phosphate tribasic (K3PO4), diammonium hydrogen phosphate ((NH4)2HPO4), ammonium phosphate trihydrate ((NH4)3PO4.3H2O), sodium hydrogen carbonate (NaHCO3), sodium carbonate Na2CO3, and their mixture.
- 25. The method according to item 18, wherein step (c) further comprises removing a portion of liquid from said paste, so that a liquid/powder ratio of said paste decreases.
- 26. The method according to item 18, wherein step (c) further comprises pressurizing said paste in said mold before said hardening reaction is complete to remove a portion of liquid from said paste, so that a liquid/powder ratio of said paste decreases.
- 27. The method according to item 26, wherein said pressuring is about 1 to 500 MPa.
- 28. The method according to item 26, wherein step (c) further comprises heating said paste during said pressurizing.
- 29. The method according to item 18, wherein step (c) further comprises heating said paste during molding.
- 30. The method according to item 1 further comprising removing the resulting porous shaped article having an increased compressive strength from said impregnating liquid; and cleaning and drying said porous shaped article after removed from said impregnating liquid.
- 31. The method according to item 30 further comprising heating the resulting cleaned and dried porous shaped article.
- 32. The method according to item 31, wherein said heating is conducted at a temperature between 50 and 500° C.
- 33. The method according to item 1, wherein said paste in step i) further comprises living cells.
- 34. The method according to item 1, wherein said immersing liquid in step ii) comprises living cells.
- 35. The method according to item 1, wherein said impregnating liquid in step iv) comprises living cells.
- 36. The method according to item 1, wherein said porous shaped article having an increased compressive strength removed from said impregnating liquid in step iv) has a porosity of at least 30 vol %.
- 37. The method according to item 1, wherein said porous shaped article having an increased compressive strength removed from said impregnating liquid in step iv) has a porosity of 50-90 vol %.
- The porous shaped calcium phosphate article made according to the method of the present invention may be used as a tissue-engineered scaffold, medical implant or a reinforcing constituent of a composite.
- The following examples are intended to demonstrate the invention more fully without acting as a limitation upon its scope, since numerous modifications and variations will be apparent to those skilled in this art.
- A Ca4(PO4)2O (TTCP) powder was prepared by mixing Ca2P2O7 powder with CaCO3 powder uniformly in ethanol for 24 hours followed by heating to dry. The mixing ratio of Ca2P2O7 powder to CaCO3 powder was 1:1.27 (weight ratio) and the powder mixture was heated to 1400° C. to allow two powders to react to form TTCP.
- The TTCP powder prepared according to the method of PREPARATIVE EXAMPLE 1 was sieved and blended with dried CaHPO4 (DCPA) powder in a ball mill for 12 hours. The blending ratio of the TTCP powder to the DCPA powder was 1:1 (molar ratio). The resultant powder mixture was added to a 25 mM diluted solution of phosphate to obtain a powder/solution mixture having a concentration of 3 g powder mixture per 1 ml solution while stirring. The resulting powder/solution mixture was formed into pellets, and the pellets were heated in an oven at 50° C. for 10 minutes. The pellets were then uniformly ground in a mechanical mill for 20 minutes to obtain the non-dispersive TTCP/DCPA-based CPC powder (ND-CPC). The particles of this ND-CPC powder have whiskers on the surfaces thereof.
- To a setting solution of 1 M phosphoric acid solution (pH=5.89) the ND-CPC powder from PREPARATIVE EXAMPLE 2 was added in a liquid/powder ratio (L/P ratio) of 0.4, i.e. 4 ml liquid/10 g powder, while stirring. KCl powder in a predetermined amount was mixed to the resulting mixture by stirring intensively. The resulting paste was filled into a cylindrical steel mold having a length of 12 mm and a diameter of 6 mm, and was compressed with a gradually increased pressure until a maximum pressure of 3.5 MPa was reached. The maximum pressure was maintained for one minute, and then the compressed CPC block was removed from the mold. At the 15th minute following the mixing of the liquid and powders, the compressed CPC block was immersed in a deionized water at 37° C. for 4 day, 8 days, and 16 days. The compressive strength of the specimens of the three different periods of immersion time was measured by using a AGS-500D mechanical tester (Shimadzu Co., Ltd., Kyoto, Japan) after the specimens were dry. The measured dry specimen compressive strength is listed Table 1.
TABLE 1 KCl/CPC Dry compressive strength (MPa) ratio by Immersion time (Day) weight 4 day 8 days 16 days 1 7.0 5.4 6.6 1.5 3.9 2.7 4.3 2 1.3 2.3 2.6 - It can seen from Table 1 that the dry compressive strength of the porous CPC blocks decreases as the KCl/CPC ratio by weight increases.
- The procedures of EXAMPLE 1 were repeated except that the immersion time was set at four days, and more KCl/CPC ratios by weight were chosen. The results are listed in Table 2.
TABLE 2 KCl/CPC ratio Dry compressive by weight strength (MPa) Porosity (vol %)* 1 8.0 66.8 1.25 5.0 69.7 1.5 3.9 72.2 1.75 2.9 74.4 2 1.3 76.5 3 0.4 81.9
*Porosity (vol %) was measured by Archimedes' method, and calculated as in ASTM C830.
- The results in Table 2 show that the porosity of the porous CPC block becomes greater as the KCl/CPC ratio by weight increases. Morphology of the porous CPC blocks prepared in this example with the KCl/CPC ratios by weight of 1.25, 1.5, 1.75 and 2.0 shows macro and micro-pores, which were observed with SEM.
- The procedures of EXAMPLE 1 were repeated except that the immersing time was set at 4 days and the resulting porous CPC block was heat treated. The heat treatment included placing the porous CPC block in an oven at 50° C. for 1 day; and then heating the dried porous CPC block in a furnace at the temperature and for a period of time set in Table 3 with a heating rate of 10° C./min. The compressive strength was measured after cooling of the heated CPC block. The conditions and results are listed in Table 3.
TABLE 3 KCl/CPC ratio Heat treatment Dry compressive by weight conditions strength (MPa) 1 No 7 350° C., 1 hr 8.5 350° C., 2 hrs 9.6 1.5 No 3.9 400° C., 2 hr 4.6 - The data in Table 3 show that the heat treatment can enhance the dry compressive strength of the porous CPC block.
- The procedures of EXAMPLE 1 were repeated except that the maximum pressure used to compress the paste in the mold was changed from 3.5 MPa to the values listed in Table 4 and the immersion conditions were also changed as indicated in Table 4. Further, the KCl/CPC ratio by weight was set at 2. The conditions and results are listed in Table 4.
TABLE 4 Mold Dry compressive pressure Immersion conditions strength (MPa) 3.5 MPa 37° C. Deionized water, 4 days 1.3 50 MPa 37° C. Deionized water, 4 days 4.7 156 MPa 37° C. Hanks' solution, 1 day; 5 37° C. deionized water, 3 days 156 MPa 37° C. Deionized water, 1 day; 4.2 37° C. Hanks' solution 3 days 156 MPa 37° C. Hanks' solution, 8 days 6 167 MPa 90° C. deionized water, 5 hrs 2.7 167 MPa 90° C. deionized water, 5 hrs; 3.7 Hank.s solution 4 days - The data in Table 4 reveal that the dry compressive strength of the porous CPC block increases as the pressure used to compress the paste in the mold increases.
- The procedures of EXAMPLE 1 were repeated by using sugar, KI, C17H33COONa and C13H27COOH instead of KCl. The immersion time was 14 days in deionized water. In the cases where the C17H33COONa and C13H27COOH were used, the CPC blocks were further immersed in ethanol for additional four days. The conditions and the results are listed in Table 4.
TABLE 5 Pore-forming powder Sa) C.S. (MPa)b) Porosity (vol %)c) Sugar 1 4.1 58.4 KI 2 4.3 62.2 KI 3 1.7 75.5 C17H33COONa 1 8.0 56.0 C13H27COOH 2 5.9 60.1
a)S = Pore-forming powder/CPC by volume.
b)C.S. = dry compressive strength (hereinafter abbreviated as C.S.).
c)Porosity: defined as in Table 2 (hereinafter the same definition will be used unless otherwise indicated).
- It can be seen from Table 5 that various powders which are soluble in water can be used in the preparation of a porous CPC block according to the method of the present invention.
- In this example various immersing liquids at different temperatures were used to prepare porous CPC blocks by repeating the procedures in EXAMPLE 1, wherein the immersion time was set at 14 days, KI was used to replace KCl, and KI/CPC ratio by volume was set at 3. The conditions and results are listed in Table 6.
TABLE 6 Immersion immersion solution temperature (° C.) C.S. Porosity % deionized water 37 1.76 75.5 deionized water 25 2.2 — Ca(OH)2 (0.03 M) 37 2.06 74.7 NaOH (0.03 M) 37 2.14 75.1 CaCl2 (0.03 M) 37 2.03 75.2 NaOH (0.03 M) 25 2.54 73.1 - It can been seen from Table 6 that various aqueous solutions which are able to dissolve the pore-forming powder can be used in the preparation of a porous CPC block according to the method of the present invention.
- The procedures of EXAMPLE 1 were repeated except that the immersion time was set at 14 days, KI was used to replace KCl, and KI/CPC ratio by volume was set at 3. Further the porous CPC block removed from the immersing liquid (deionized water at 37° C.) was dried in an oven and then subjected to a heat treatment at 100-800° C. for a period of 2-10 hours in high temperature furnace with a heating rate of 10° C./min. The conditions and results are listed in Table 7.
TABLE 7 Heat treatment condition C.S. (MPa) No 1.7 100° C. - 2 hr 1.7 200° C. - 2 hr 2.4 400° C. - 2 hr 2.7 600° C. - 2 hr 1.5 800° C. - 2 hr 1.4 400° C. - 10 hr 2.2 800° C. - 10 hr 1.4 - As shown in Table 7 the optimal conditions for the heat treatment is 400° C. for two hours, thereby the dry compressive strength of the porous CPC block was increased from 1.7 to 2.7 MPa.
- The procedures of EXAMPLE 1 were repeated except that NaCl was used to replace KCl, and NaCl/CPC ratio by weight was set in Table 8. Further the paste was immersed in the immersing liquid (deionized water at 37° C. and 60° C.) for 7 days. The conditions and results are listed in Table 8.
TABLE 8 Dry compressive strength (MPa) NaCl/CPC ratio Immersion temperatue (° C.) by weight 37 60 0 75.5 58.2 0.25 28.8 27.9 0.5 11.2 10.4 0.75 5.8 8.3 1 6.7 6.1 1.25 — 5.2 Porosity (%) NaCl/CPC ratio Immersion temperatue (° C.) by weight 37 60 0 33.3 37.3 0.25 46.1 41.9 0.5 49.4 54.3 0.75 56.1 59.4 1 — 64.2 1.25 63.9 67.9 - The procedures of EXAMPLE 1 were repeated except that NaCl was used to replace KCl, the paste was immersed in the immersing liquid (deionized water at 37° C.) for 7 days, and NaCl/CPC ratio by weight was set in Table 9. Further the resulting porous CPC block was heat treated. The heat treatment included heating the porous CPC block in a furnance at the temperature set in Table 9 for 1 hr with a heating rate of 10° C./min. The compressive strength was measured after cooling of the heated CPC block. The conditions and results are listed in Table 9.
TABLE 9 Dry compressive strength (MPa) Heat treatment NaCl/CPC ratio by weight temperatue (° C.) 0.25 0.5 Without heat treatment 28.8 11.2 50 38.8 16.1 100 36.8 21.0 200 46.1 29.5 350 54.5 30.0 400 39.4 29.5 450 36.6 18.3 - In the other preferred embodiments of the present invention Na2CO3 was used as the pore-forming powder in the preparation of the porous CPC blocks, which had the dry compressive strength and the porosity comparable to those disclosed in Examples 1-9.
- Although the present invention has been described with reference to specific details of certain embodiments thereof, it is not intended that such details should be regarded as limitations upon the scope of the invention except as and to the extent that they are included in the accompanying claims. Many modifications and variations are possible in light of the above disclosure.
Claims (22)
1-37. (canceled)
38. A method of forming a porous calcium phosphate article comprising:
adding a paste to a mold, wherein the paste comprises at least one calcium phosphate compound combined with at least one pore forming powder and at least one setting agent;
forming a hardened calcium phosphate article from the paste;
immersing the hardened calcium phosphate article in one or more liquids to form a porous calcium phosphate article; and
subjecting the immersed porous calcium phosphate article to one or more heat treatments, wherein the temperature of the heat treatments is from about 50° C. to about 500° C.
39. The method of claim 38 , wherein the calcium phosphate compound is selected from the group consisting of alpha-tricalcium phosphate (α-TCP), beta-tricalcium phosphate (β-TCP), tetracalcium phosphate (TTCP), monocalcium phosphate monohydrate (MCPM), monocalcium phosphate anhydrous (MCPA), dicalcium phosphate dihydrate (DCPD), dicalcium phosphate anhydrous (DCPA), octacalcium phosphate (OCP), calcium dihydrogen phosphate, calcium dihydrogen phosphate hydrate, acid calcium pyrophosphate, anhydrous calcium hydrogen phosphate, calcium hydrogen phosphate hydrate, calcium pyrophosphate, calcium triphosphate, calcium phosphate tribasic, calcium polyphosphate, calcium metaphosphate, anhydrous tricalcium phosphate, tricalcium phosphate hydrate, and amorphous calcium phosphate.
40. The method of claim 38 , wherein the calcium phosphate compound comprises at least one calcium phosphate particulate cmpound having calcium phosphate whiskers on the surface of the particles, wherein said calcium phosphate whiskers have a length of about 1-5000 nm and a width of about 1-500 nm.
41. The method of claim 38 , wherein the pore forming powder is at least partially water-soluble.
42. The method of claim 38 , wherein the pore forming powder comprises an inorganic salt.
43. The method of claim 38 , wherein the pore forming powder comprises an organic salt.
44. The method of claim 38 , wherein the pore forming powder is selected from the list consisting of LiCl, KCl, NaCl, MgCl2, CaCl2, NaIO3, KI, Na3PO4, K3PO4, Na2CO3, amino acid-sodium salt, amino acid-potassium salt, glucose, polysaccharide, fatty acid-sodium salt, fatty acid-potassium salt, potassium bitartrate (KHC4H4O6), potassium carbonate, potassium gluconate (KC6H11O7), potassium-sodium tartrate (KNaC4H4O6.4H2O), potassium sulfate (K2SO4), sodium sulfate, and sodium lactate.
45. The method of claim 38 , wherein the weight ratio of pore forming powder-to-calcium phosphate cement is from about to 0.25 to about 3.0.
46. The method of claim 38 , wherein the setting agent comprises an acidic solution, a basic solution, or substantially pure water.
47. The method of claim 46 , wherein said acidic solution is selected from the group consisting of nitric acid (HNO3), hydrochloric acid (HCl), phosphoric acid (H3PO4), carbonic acid (H2CO3), sodium dihydrogen phosphate (NaH2PO4), sodium dihydrogen phosphate monohydrate (NaH2PO4.H2O), sodium dihydrogen phosphate dihydrate, sodium dihydrogen phosphate dehydrate, potassium dihydrogen phosphate (KH2PO4), ammonium dihydrogen.phosphate (NH4H2PO4), malic acid, acetic acid, lactic acid, citric acid, malonic acid, succinic acid, glutaric acid, tartaric acid, oxalic acid and mixtures thereof.
48. The method of claim 46 , wherein said basic solution is selected from the group consisting of ammonia, ammonium hydroxide, alkali metal hydroxide, alkali earth hydroxide, disodium hydrogen phosphate (Na2HPO4), disodium hydrogen phosphate dodecahydrate, disodium hydrogen phosphate heptahydrate, sodium phosphate dodecahydrate (Na3PO4.12H2O), dipotassium hydrogen phosphate (K2HPO4), potassium hydrogen phosphate trihydrate (K2HPO4.3H2O), potassium phosphate tribasic (K3PO4), diammonium hydrogen phosphate ((NH4)2HPO4), ammonium phosphate trihydrate ((NH4)3PO4.3H2O), sodium hydrogen carbonate (NaHCO3), sodium carbonate Na2CO3, and mixtures thereof.
49. The method of claim 38 , further comprising subjecting the paste to a molding pressure of greater than 1 MPa.
50. The method of claim 38 , further comprising reducing the liquid-to-powder ratio of the paste by removing at least a portion of liquid from the paste.
51. The method of claim 38 , wherein the article is adapted for use as a medical impant.
52. The method of claim 38 , wherein the one or more liquids comprises a basic solution, an acidic solution, a solution of substantially physiological pH, an organic solvent, or substantially pure water.
53. The method of claim 38 , wherein at least one of the liquids comprises at least one of a solution of HCl, a solution of (NH4)2HPO4, or Hank's solution.
54. The method of claim 38 , wherein the immersion liquid comprises at least one source of calcium and at least one source of phosphate.
55. The method of claim 38 , wherein the hardened calcium phosphate article is immersed in one or more liquids for a period of time sufficient to remove at least a portion of the pore forming powder from the calcium phosphate article.
56. The method of claim 38 , wherein the hardened calcium phosphate article is immersed in at least one immersing liquid for at least 24 hours.
57. The method of claim 38 , wherein the paste further comprises living cells.
58. The method of claim 38 , wherein the immersing liquid further comprises living cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/071,631 US7083750B2 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/780,728 US7163651B2 (en) | 2004-02-19 | 2004-02-19 | Method for making a porous calcium phosphate article |
US11/071,631 US7083750B2 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/780,728 Continuation US7163651B2 (en) | 2003-08-05 | 2004-02-19 | Method for making a porous calcium phosphate article |
Publications (2)
Publication Number | Publication Date |
---|---|
US20050186353A1 true US20050186353A1 (en) | 2005-08-25 |
US7083750B2 US7083750B2 (en) | 2006-08-01 |
Family
ID=34860899
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/780,728 Expired - Fee Related US7163651B2 (en) | 2003-08-05 | 2004-02-19 | Method for making a porous calcium phosphate article |
US11/071,803 Expired - Fee Related US7097793B2 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
US11/071,631 Expired - Fee Related US7083750B2 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
US11/071,802 Abandoned US20050186449A1 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
US11/071,767 Expired - Fee Related US7119038B2 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/780,728 Expired - Fee Related US7163651B2 (en) | 2003-08-05 | 2004-02-19 | Method for making a porous calcium phosphate article |
US11/071,803 Expired - Fee Related US7097793B2 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/071,802 Abandoned US20050186449A1 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
US11/071,767 Expired - Fee Related US7119038B2 (en) | 2004-02-19 | 2005-03-03 | Method for making a porous calcium phosphate article |
Country Status (1)
Country | Link |
---|---|
US (5) | US7163651B2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030216777A1 (en) * | 2002-05-16 | 2003-11-20 | Yin-Chun Tien | Method of enhancing healing of interfacial gap between bone and tendon or ligament |
US20050184418A1 (en) * | 2004-02-19 | 2005-08-25 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
US20050263928A1 (en) * | 2004-05-25 | 2005-12-01 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
US20050268820A1 (en) * | 2000-07-13 | 2005-12-08 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
US20050271741A1 (en) * | 2000-07-13 | 2005-12-08 | Cana Lab Corporation | Injectable calcium phosphate cements and the preparation and use thereof |
US20050274287A1 (en) * | 2000-07-13 | 2005-12-15 | Lin Jiin-Huey C | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
US20050274288A1 (en) * | 1999-07-14 | 2005-12-15 | Lin Jiin-Huey C | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
US7754246B2 (en) | 2005-09-09 | 2010-07-13 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
US8025903B2 (en) | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
CN102973983A (en) * | 2012-12-02 | 2013-03-20 | 复旦大学 | Water-soluble pore-foaming agent, porous scaffold and preparation method of porous scaffold |
EP2621869A2 (en) * | 2010-10-01 | 2013-08-07 | Skeletal Kinetics LLC | Porogen containing calcium phosphate cement compositions |
CN104098075A (en) * | 2014-06-19 | 2014-10-15 | 洛阳威乐美科技有限公司 | Preparation method of superfine calcium phosphate powder |
US20160075599A1 (en) * | 2013-04-22 | 2016-03-17 | Mathys Ag Bettlach | Calcium phosphate cement composition |
US9446170B2 (en) | 2013-12-13 | 2016-09-20 | Agnovos Healthcare, Llc | Multiphasic bone graft substitute material |
CN107106729A (en) * | 2014-11-17 | 2017-08-29 | 海洋纳米技术有限公司 | Bioactivity wound dressing and tooth coating based on the amorphous calcium polyphosphate with morphogenic activity |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7169373B2 (en) * | 1999-07-14 | 2007-01-30 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
US7270705B2 (en) * | 1999-07-14 | 2007-09-18 | Jiin-Huey Chern Lin | Method of increasing working time of tetracalcium phosphate cement paste |
US7156915B2 (en) * | 2000-07-13 | 2007-01-02 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) with surface whiskers and method of making same |
CA2489242A1 (en) * | 2002-07-12 | 2004-01-22 | Robert M. Pilliar | Method of manufacture of porous inorganic structures and infiltration with organic polymers |
WO2006119272A2 (en) * | 2005-05-04 | 2006-11-09 | Rosenthal Collins Group, Llc | Method and system for providing automatic exeuction of black box strategies for electronic trading |
US8309128B2 (en) * | 2005-06-10 | 2012-11-13 | Pierre Fabre Medicament | Stabilized milnacipran formulation |
CN100425295C (en) * | 2006-09-19 | 2008-10-15 | 天津大学 | Premix plaster calcium phosphate bone cement |
US8114336B2 (en) * | 2007-03-16 | 2012-02-14 | Board Of Regents Of The University Of Texas System | Methods for increasing the strength and controlling the architecture and composition of ceramic articles |
ITRM20070363A1 (en) | 2007-06-27 | 2008-12-28 | Univ Bologna Alma Mater | POROUS SECTOR FROM CEMENTITIOUS MATERIAL OF CALCIUM PHOSPHATE AND ITS USE IN FLUID-SCALE EQUIPMENT |
EP2014256A1 (en) * | 2007-07-12 | 2009-01-14 | Straumann Holding AG | Composite bone repair material |
WO2009108934A2 (en) * | 2008-02-28 | 2009-09-03 | Osteotherapeutics, L.L.C. | Injectable calcium phosphate cememts formulated with bioactive agents and methods for making same |
US9399086B2 (en) * | 2009-07-24 | 2016-07-26 | Warsaw Orthopedic, Inc | Implantable medical devices |
EP2512537B1 (en) * | 2009-12-18 | 2015-08-26 | Howmedica Osteonics Corp. | Dual paste direct injectable bone cement precursor systems and methods of making same |
TWI411595B (en) * | 2010-04-07 | 2013-10-11 | Univ Kaohsiung Medical | Process for preparing composition comprising porous ceramic with thermo-response hydrogel |
ES2714701T3 (en) | 2010-11-10 | 2019-05-29 | Stryker European Holdings I Llc | Process for the preparation of a polymeric bone foam |
EP3134372B1 (en) | 2014-04-24 | 2019-12-04 | OssDsign AB | Methods of forming a porous ceramic shaped article |
WO2016088915A1 (en) | 2014-12-03 | 2016-06-09 | 한국기계연구원 | Support for hard tissue regeneration containing active ingredient for osteoporosis treatment, and method for preparing same |
CN105107023A (en) * | 2015-07-01 | 2015-12-02 | 李亚屏 | Degradable porous composite scaffold material for bone transplantation |
Citations (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679360A (en) * | 1970-06-26 | 1972-07-25 | Nasa | Process for the preparation of brushite crystals |
US4371484A (en) * | 1980-06-13 | 1983-02-01 | Mitsubishi Mining & Cement Co., Ltd. | Process for making porous sintered body of calcium phosphate |
US4481175A (en) * | 1982-12-14 | 1984-11-06 | Mitsui Toatsu Chemicals, Inc. | Process for preparing apatite |
US4518430A (en) * | 1982-04-29 | 1985-05-21 | American Dental Association Health Foundation | Dental resptorative cement pastes |
US4612053A (en) * | 1983-10-06 | 1986-09-16 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
USRE33161E (en) * | 1982-04-29 | 1990-02-06 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
USRE33221E (en) * | 1982-04-29 | 1990-05-22 | American Dental Association Health Foundation | Dental restorative cement pastes |
US4959104A (en) * | 1985-10-11 | 1990-09-25 | Mitsui Toatsu Chemicals, Inc. | Self-hardenable material |
US5017518A (en) * | 1987-09-14 | 1991-05-21 | Asahi Kogaku Kogyo K.K. | Process for producing calcium phosphate ceramics having porous surface |
US5053212A (en) * | 1988-04-20 | 1991-10-01 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
US5092888A (en) * | 1989-05-19 | 1992-03-03 | Tokuyama Soda Kabushiki Kaisha | Hardening material |
US5149368A (en) * | 1991-01-10 | 1992-09-22 | Liu Sung Tsuen | Resorbable bioactive calcium phosphate cement |
US5152791A (en) * | 1989-12-07 | 1992-10-06 | Olympus Optical Co., Ltd. | Prosthetic artificial bone having ceramic layers of different porosity |
US5180426A (en) * | 1987-12-28 | 1993-01-19 | Asahi Kogaku Kogyo K.K. | Composition for forming calcium phosphate type setting material and process for producing setting material |
US5336264A (en) * | 1988-04-20 | 1994-08-09 | Norian Corporation | Situ prepared calcium phosphate composition and method |
US5338356A (en) * | 1991-10-29 | 1994-08-16 | Mitsubishi Materials Corporation | Calcium phosphate granular cement and method for producing same |
US5342441A (en) * | 1991-06-26 | 1994-08-30 | Nitta Gelatin Inc. | Biologically compatible hardening material for dental or medical applications |
US5409982A (en) * | 1990-07-27 | 1995-04-25 | Osaka Cement Co. Ltd. | Tetracalcium phosphate-based materials and process for their preparation |
US5492768A (en) * | 1992-10-08 | 1996-02-20 | Kyocera Corporation | Porous living body repairing member, and a method of imparting elasticity to it |
US5496399A (en) * | 1994-08-23 | 1996-03-05 | Norian Corporation | Storage stable calcium phosphate cements |
US5503164A (en) * | 1994-01-28 | 1996-04-02 | Osteogenics, Inc. | Device and method for repair of craniomaxillofacial bone defects including burr holes |
US5522893A (en) * | 1993-03-12 | 1996-06-04 | American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5525148A (en) * | 1993-09-24 | 1996-06-11 | American Dental Association Health Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
US5550172A (en) * | 1995-02-07 | 1996-08-27 | Ethicon, Inc. | Utilization of biocompatible adhesive/sealant materials for securing surgical devices |
US5605713A (en) * | 1991-11-22 | 1997-02-25 | Boltong; Maria G. | Process for the preparation of calcium phosphate cements and its application as bio-materials |
US5607685A (en) * | 1994-02-09 | 1997-03-04 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Protracted-release adminstration forms containing clindamycin palmitate |
US5766669A (en) * | 1995-08-24 | 1998-06-16 | Millenium Biologix Inc. | Sintering process for producing thin films of calcium phosphate entities |
US5782971A (en) * | 1991-06-28 | 1998-07-21 | Norian Corporation | Calcium phosphate cements comprising amorophous calcium phosphate |
US5814681A (en) * | 1994-10-13 | 1998-09-29 | Kuraray Co., Ltd. | Restorative composition for hard tissue and dispensing apparatus therefor |
US5891448A (en) * | 1995-01-06 | 1999-04-06 | American Dental Association Health Foundation | Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
US5899939A (en) * | 1998-01-21 | 1999-05-04 | Osteotech, Inc. | Bone-derived implant for load-supporting applications |
US5958430A (en) * | 1998-02-20 | 1999-09-28 | Battelle Memorial Institute | Thin film composition with biological substance and method of making |
US6013591A (en) * | 1997-01-16 | 2000-01-11 | Massachusetts Institute Of Technology | Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production |
US6013853A (en) * | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
US6018095A (en) * | 1996-06-14 | 2000-01-25 | Bioland | Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor |
US6027742A (en) * | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
US6077989A (en) * | 1996-05-28 | 2000-06-20 | Kandel; Rita | Resorbable implant biomaterial made of condensed calcium phosphate particles |
US6118043A (en) * | 1991-06-26 | 2000-09-12 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Bone replacement material with FGF |
US6117456A (en) * | 1995-05-19 | 2000-09-12 | Etex Corporation | Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
US6123731A (en) * | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US6132463A (en) * | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
US6277149B1 (en) * | 1999-06-08 | 2001-08-21 | Osteotech, Inc. | Ramp-shaped intervertebral implant |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6340648B1 (en) * | 1999-04-13 | 2002-01-22 | Toshiba Ceramics Co., Ltd. | Calcium phosphate porous sintered body and production thereof |
US6379453B1 (en) * | 1999-07-14 | 2002-04-30 | Jiin-Huey Chern | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20020073894A1 (en) * | 2000-10-16 | 2002-06-20 | University Of South Carolina Research Foundation | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement |
US20020119635A1 (en) * | 2000-01-21 | 2002-08-29 | Bae Systems Information And Electronic Systems Integration, Inc. | Integrated resistor having aligned body and contact and method for forming the same |
US20020137812A1 (en) * | 2001-01-24 | 2002-09-26 | American Dental Association Health Foundation | Premixed calcium phosphate cement pastes |
US6458162B1 (en) * | 1999-08-13 | 2002-10-01 | Vita Special Purpose Corporation | Composite shaped bodies and methods for their production and use |
US20030021824A1 (en) * | 2000-03-01 | 2003-01-30 | Jean-Louis Lacout | Method for preparing a calcium phosphate pasty material for injection |
US20030019396A1 (en) * | 2000-10-30 | 2003-01-30 | Howmedica Osteonics Corp. | Porous calcium phosphate cement |
US20030031698A1 (en) * | 2000-01-31 | 2003-02-13 | Roeder Ryan K. | Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods |
US20030039676A1 (en) * | 1999-02-23 | 2003-02-27 | Boyce Todd M. | Shaped load-bearing osteoimplant and methods of making same |
US20030055512A1 (en) * | 2001-05-21 | 2003-03-20 | Genin Francois Y. | Calcium based neutral and bioresorbable bone graft |
US20030074081A1 (en) * | 2000-09-22 | 2003-04-17 | Ayers Reed A. | Non-uniform porosity tissue implant |
US20030078317A1 (en) * | 2001-08-30 | 2003-04-24 | Jiin-Huey Lin | Process for preparing a paste from calcium phosphate cement |
US6569489B1 (en) * | 1998-03-11 | 2003-05-27 | Depuy Orthopaedics, Inc. | Bioactive ceramic coating and method |
US20030120351A1 (en) * | 2001-12-21 | 2003-06-26 | Etex Corporation | Synthesis of calcium phosphates by mechano-chemical process |
US6585992B2 (en) * | 1995-09-01 | 2003-07-01 | Millenium Biologix, Inc. | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity |
US20030121450A1 (en) * | 1999-07-14 | 2003-07-03 | Jiin-Huey Chern Lin | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20030167093A1 (en) * | 2002-03-01 | 2003-09-04 | American Dental Association Health Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
US20040003757A1 (en) * | 1999-07-14 | 2004-01-08 | Cana Lab Corporation | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
US20040022825A1 (en) * | 2001-12-21 | 2004-02-05 | Lagow Richard J. | Calcium phosphate bone replacement materials and methods of use thereof |
US20040031420A1 (en) * | 2000-07-13 | 2004-02-19 | Lin Jiin-Huey Chern | Calcium phosphate cement, use and preparation thereof |
US6719989B1 (en) * | 1999-09-08 | 2004-04-13 | Pentax Corporation | Sustained release drug carrier, and method of manufacturing sustained release drug carrier |
US20040076685A1 (en) * | 2002-07-11 | 2004-04-22 | Merck Patent Gmbh | Method of preparing porous calcium phosphate morsels and granules via gelatin processing |
US6752831B2 (en) * | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
US20040137032A1 (en) * | 2002-03-15 | 2004-07-15 | Wang Francis W. | Combinations of calcium phosphates, bone growth factors, and pore-forming additives as osteoconductive and osteoinductive composite bone grafts |
US20040175320A1 (en) * | 1999-07-14 | 2004-09-09 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
US20040180091A1 (en) * | 2003-03-13 | 2004-09-16 | Chang-Yi Lin | Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
US20040186481A1 (en) * | 2003-03-21 | 2004-09-23 | Cana Lab Corporation | Method for forming a hardened cement in a bone cavity |
US20040185181A1 (en) * | 2000-12-07 | 2004-09-23 | Pentax Corporation | Porous sintered body of calcium phosphate-based ceramic and method for producing same |
US20050008759A1 (en) * | 2003-07-11 | 2005-01-13 | Li Nie | Grain protein-based formulations and methods of using same |
US20050101964A1 (en) * | 2003-11-07 | 2005-05-12 | Calcitec, Inc. | Spinal fusion procedure using an injectable bone substitute |
US6929692B2 (en) * | 2002-08-27 | 2005-08-16 | Biomet Deutschland Gmbh | Calcium phosphate cement composition and a method for the preparation thereof |
US20050184417A1 (en) * | 2004-02-19 | 2005-08-25 | Cana Lab Corporation | Method for making a porous calcium phosphate article |
US6953594B2 (en) * | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US560713A (en) * | 1896-05-26 | Fire-escape | ||
US455272A (en) * | 1891-06-30 | Hermann bormann | ||
US526166A (en) * | 1894-09-18 | Harvester-elevator | ||
US629041A (en) * | 1899-04-03 | 1899-07-18 | Henry J Mark | Partition-packing. |
US4553272A (en) | 1981-02-26 | 1985-11-19 | University Of Pittsburgh | Regeneration of living tissues by growth of isolated cells in porous implant and product thereof |
DE3479402D1 (en) | 1984-06-12 | 1989-09-21 | Oscobal Ag | Method of producing a bone replacement material |
US4950296A (en) | 1988-04-07 | 1990-08-21 | Mcintyre Jonathan L | Bone grafting units |
US6005162A (en) * | 1988-04-20 | 1999-12-21 | Norian Corporation | Methods of repairing bone |
DE58902022D1 (en) * | 1988-04-22 | 1992-09-17 | Mathys Ag | MARKER ROOM LOCK. |
US5164187A (en) | 1990-04-05 | 1992-11-17 | Norian Corporation | Hydroxyapatite prosthesis coatings |
US5262166A (en) * | 1991-04-17 | 1993-11-16 | Lty Medical Inc | Resorbable bioactive phosphate containing cements |
US5218035A (en) * | 1992-02-03 | 1993-06-08 | Liu Sung Tsuen | Phosphate-containing surgical cements |
US5476647A (en) * | 1993-09-13 | 1995-12-19 | American Dental Association Health Foundation | Complex calcium and fluoride containing mouth rinses, dentifrices, and chewable tablets |
US5675729A (en) * | 1993-10-22 | 1997-10-07 | Sun Microsystems, Inc. | Method and apparatus for performing on-chip measurement on a component |
US5676976A (en) * | 1995-05-19 | 1997-10-14 | Etex Corporation | Synthesis of reactive amorphous calcium phosphates |
US5702449A (en) | 1995-06-07 | 1997-12-30 | Danek Medical, Inc. | Reinforced porous spinal implants |
US6149688A (en) | 1995-06-07 | 2000-11-21 | Surgical Dynamics, Inc. | Artificial bone graft implant |
CN1244815A (en) * | 1996-12-13 | 2000-02-16 | 诺瑞安有限公司 | Preparation, storage and administration of cements |
US5939039A (en) * | 1997-01-16 | 1999-08-17 | Orthovita, Inc. | Methods for production of calcium phosphate |
DE69809158T2 (en) * | 1997-08-28 | 2003-03-20 | Ngk Spark Plug Co | Calcium phosphate cement and calcium phosphate cement composition |
SE515695C2 (en) * | 1999-05-31 | 2001-09-24 | Nobel Biocare Ab | Implant with coating of bone growth stimulant for bone application and procedure in such implant |
US7270705B2 (en) * | 1999-07-14 | 2007-09-18 | Jiin-Huey Chern Lin | Method of increasing working time of tetracalcium phosphate cement paste |
US6162258A (en) * | 1999-08-25 | 2000-12-19 | Osteotech, Inc. | Lyophilized monolithic bone implant and method for treating bone |
EP1153621A1 (en) * | 2000-05-12 | 2001-11-14 | MERCK PATENT GmbH | Biocements based on a mixture of TCP-PHA with improved compressive strength |
US6533821B1 (en) * | 2000-06-22 | 2003-03-18 | Thomas Lally | Bio-adhesive composition, method for adhering objects to bone |
US6325804B1 (en) * | 2000-06-28 | 2001-12-04 | Ethicon, Inc. | Method for fixing a graft in a bone tunnel |
US6332779B1 (en) * | 2000-07-03 | 2001-12-25 | Osteotech, Inc. | Method of hard tissue repair |
TR200400527T4 (en) | 2000-07-03 | 2004-07-21 | Osteotech Inc. | Bone-derived osteogenic implants |
US6619489B2 (en) * | 2000-09-21 | 2003-09-16 | L & P Property Management Company | Wire rack for wine bottles and the like |
EP1492475B1 (en) | 2001-04-16 | 2011-12-21 | Wright Medical Technology, Inc. | Dense/porous structures for use as bone substitutes |
US6478825B1 (en) * | 2001-11-28 | 2002-11-12 | Osteotech, Inc. | Implant, method of making same and use of the implant for the treatment of bone defects |
US6648960B1 (en) * | 2002-06-26 | 2003-11-18 | Cana Lab Corporation | Method of shortening a working and setting time of a calcium phosphate cement (CPC) paste |
US7118705B2 (en) * | 2003-08-05 | 2006-10-10 | Calcitec, Inc. | Method for making a molded calcium phosphate article |
US6994726B2 (en) * | 2004-05-25 | 2006-02-07 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
-
2004
- 2004-02-19 US US10/780,728 patent/US7163651B2/en not_active Expired - Fee Related
-
2005
- 2005-03-03 US US11/071,803 patent/US7097793B2/en not_active Expired - Fee Related
- 2005-03-03 US US11/071,631 patent/US7083750B2/en not_active Expired - Fee Related
- 2005-03-03 US US11/071,802 patent/US20050186449A1/en not_active Abandoned
- 2005-03-03 US US11/071,767 patent/US7119038B2/en not_active Expired - Fee Related
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679360A (en) * | 1970-06-26 | 1972-07-25 | Nasa | Process for the preparation of brushite crystals |
US4371484A (en) * | 1980-06-13 | 1983-02-01 | Mitsubishi Mining & Cement Co., Ltd. | Process for making porous sintered body of calcium phosphate |
USRE33221E (en) * | 1982-04-29 | 1990-05-22 | American Dental Association Health Foundation | Dental restorative cement pastes |
US4518430A (en) * | 1982-04-29 | 1985-05-21 | American Dental Association Health Foundation | Dental resptorative cement pastes |
USRE33161E (en) * | 1982-04-29 | 1990-02-06 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
US4481175A (en) * | 1982-12-14 | 1984-11-06 | Mitsui Toatsu Chemicals, Inc. | Process for preparing apatite |
US4612053A (en) * | 1983-10-06 | 1986-09-16 | American Dental Association Health Foundation | Combinations of sparingly soluble calcium phosphates in slurries and pastes as mineralizers and cements |
US4959104A (en) * | 1985-10-11 | 1990-09-25 | Mitsui Toatsu Chemicals, Inc. | Self-hardenable material |
US5017518A (en) * | 1987-09-14 | 1991-05-21 | Asahi Kogaku Kogyo K.K. | Process for producing calcium phosphate ceramics having porous surface |
US5180426A (en) * | 1987-12-28 | 1993-01-19 | Asahi Kogaku Kogyo K.K. | Composition for forming calcium phosphate type setting material and process for producing setting material |
US5053212A (en) * | 1988-04-20 | 1991-10-01 | Norian Corporation | Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite |
US5820632A (en) * | 1988-04-20 | 1998-10-13 | Norian Corporation | Prepared calcium phosphate composition and method |
US5336264A (en) * | 1988-04-20 | 1994-08-09 | Norian Corporation | Situ prepared calcium phosphate composition and method |
US5092888A (en) * | 1989-05-19 | 1992-03-03 | Tokuyama Soda Kabushiki Kaisha | Hardening material |
US5152791A (en) * | 1989-12-07 | 1992-10-06 | Olympus Optical Co., Ltd. | Prosthetic artificial bone having ceramic layers of different porosity |
US5652016A (en) * | 1990-07-27 | 1997-07-29 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
US5569490A (en) * | 1990-07-27 | 1996-10-29 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
US5409982A (en) * | 1990-07-27 | 1995-04-25 | Osaka Cement Co. Ltd. | Tetracalcium phosphate-based materials and process for their preparation |
US5536575A (en) * | 1990-07-27 | 1996-07-16 | Osaka Cement Co., Ltd. | Tetracalcium phosphate-based materials and processes for their preparation |
US5149368A (en) * | 1991-01-10 | 1992-09-22 | Liu Sung Tsuen | Resorbable bioactive calcium phosphate cement |
US6118043A (en) * | 1991-06-26 | 2000-09-12 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Bone replacement material with FGF |
US5342441A (en) * | 1991-06-26 | 1994-08-30 | Nitta Gelatin Inc. | Biologically compatible hardening material for dental or medical applications |
US5782971B1 (en) * | 1991-06-28 | 1999-09-21 | Norian Corp | Calcium phosphate cements comprising amorophous calcium phosphate |
US5782971A (en) * | 1991-06-28 | 1998-07-21 | Norian Corporation | Calcium phosphate cements comprising amorophous calcium phosphate |
US5338356A (en) * | 1991-10-29 | 1994-08-16 | Mitsubishi Materials Corporation | Calcium phosphate granular cement and method for producing same |
US5605713A (en) * | 1991-11-22 | 1997-02-25 | Boltong; Maria G. | Process for the preparation of calcium phosphate cements and its application as bio-materials |
US6013853A (en) * | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
US5492768A (en) * | 1992-10-08 | 1996-02-20 | Kyocera Corporation | Porous living body repairing member, and a method of imparting elasticity to it |
US5545254A (en) * | 1993-03-12 | 1996-08-13 | The American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5542973A (en) * | 1993-03-12 | 1996-08-06 | The American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5522893A (en) * | 1993-03-12 | 1996-06-04 | American Dental Association Health Foundation | Calcium phosphate hydroxyapatite precursor and methods for making and using the same |
US5525148A (en) * | 1993-09-24 | 1996-06-11 | American Dental Association Health Foundation | Self-setting calcium phosphate cements and methods for preparing and using them |
US5954867A (en) * | 1993-09-24 | 1999-09-21 | American Dental Health Foundation Association | Self setting calcium phosphate cements and methods for preparing and using them |
US5503164A (en) * | 1994-01-28 | 1996-04-02 | Osteogenics, Inc. | Device and method for repair of craniomaxillofacial bone defects including burr holes |
US5607685A (en) * | 1994-02-09 | 1997-03-04 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Protracted-release adminstration forms containing clindamycin palmitate |
US5496399A (en) * | 1994-08-23 | 1996-03-05 | Norian Corporation | Storage stable calcium phosphate cements |
US5964932A (en) * | 1994-08-23 | 1999-10-12 | Norian Corporation | Storage stable calcium phosphate cements |
US5814681A (en) * | 1994-10-13 | 1998-09-29 | Kuraray Co., Ltd. | Restorative composition for hard tissue and dispensing apparatus therefor |
US5891448A (en) * | 1995-01-06 | 1999-04-06 | American Dental Association Health Foundation | Control of calcium fluoride formation in mouth rinses, dentifrices and gels |
US5550172A (en) * | 1995-02-07 | 1996-08-27 | Ethicon, Inc. | Utilization of biocompatible adhesive/sealant materials for securing surgical devices |
US6132463A (en) * | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
US6027742A (en) * | 1995-05-19 | 2000-02-22 | Etex Corporation | Bioresorbable ceramic composites |
US6117456A (en) * | 1995-05-19 | 2000-09-12 | Etex Corporation | Methods and products related to the physical conversion of reactive amorphous calcium phosphate |
US5766669A (en) * | 1995-08-24 | 1998-06-16 | Millenium Biologix Inc. | Sintering process for producing thin films of calcium phosphate entities |
US6585992B2 (en) * | 1995-09-01 | 2003-07-01 | Millenium Biologix, Inc. | Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity |
US6077989A (en) * | 1996-05-28 | 2000-06-20 | Kandel; Rita | Resorbable implant biomaterial made of condensed calcium phosphate particles |
US6018095A (en) * | 1996-06-14 | 2000-01-25 | Bioland | Method for preparing an implantable composite material, resulting material, implant including said material, and kit therefor |
US6953594B2 (en) * | 1996-10-10 | 2005-10-11 | Etex Corporation | Method of preparing a poorly crystalline calcium phosphate and methods of its use |
US6013591A (en) * | 1997-01-16 | 2000-01-11 | Massachusetts Institute Of Technology | Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production |
US5899939A (en) * | 1998-01-21 | 1999-05-04 | Osteotech, Inc. | Bone-derived implant for load-supporting applications |
US6294041B1 (en) * | 1998-02-06 | 2001-09-25 | Osteotech, Inc. | Method for an osteoimplant manufacture |
US6123731A (en) * | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
US5958430A (en) * | 1998-02-20 | 1999-09-28 | Battelle Memorial Institute | Thin film composition with biological substance and method of making |
US6569489B1 (en) * | 1998-03-11 | 2003-05-27 | Depuy Orthopaedics, Inc. | Bioactive ceramic coating and method |
US20030039676A1 (en) * | 1999-02-23 | 2003-02-27 | Boyce Todd M. | Shaped load-bearing osteoimplant and methods of making same |
US6696073B2 (en) * | 1999-02-23 | 2004-02-24 | Osteotech, Inc. | Shaped load-bearing osteoimplant and methods of making same |
US6440444B2 (en) * | 1999-02-23 | 2002-08-27 | Osteotech, Inc. | Load bearing osteoimplant and method of repairing bone using the same |
US6294187B1 (en) * | 1999-02-23 | 2001-09-25 | Osteotech, Inc. | Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same |
US6340648B1 (en) * | 1999-04-13 | 2002-01-22 | Toshiba Ceramics Co., Ltd. | Calcium phosphate porous sintered body and production thereof |
US6277149B1 (en) * | 1999-06-08 | 2001-08-21 | Osteotech, Inc. | Ramp-shaped intervertebral implant |
US6530955B2 (en) * | 1999-06-08 | 2003-03-11 | Osteotech, Inc. | Ramp-shaped intervertebral implant |
US20040003757A1 (en) * | 1999-07-14 | 2004-01-08 | Cana Lab Corporation | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
US6840995B2 (en) * | 1999-07-14 | 2005-01-11 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20040175320A1 (en) * | 1999-07-14 | 2004-09-09 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface and process for preparing the same |
US20050076813A1 (en) * | 1999-07-14 | 2005-04-14 | Calcitec, Inc. | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US20030121450A1 (en) * | 1999-07-14 | 2003-07-03 | Jiin-Huey Chern Lin | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US6379453B1 (en) * | 1999-07-14 | 2002-04-30 | Jiin-Huey Chern | Process for producing fast-setting, bioresorbable calcium phosphate cements |
US6458162B1 (en) * | 1999-08-13 | 2002-10-01 | Vita Special Purpose Corporation | Composite shaped bodies and methods for their production and use |
US6719989B1 (en) * | 1999-09-08 | 2004-04-13 | Pentax Corporation | Sustained release drug carrier, and method of manufacturing sustained release drug carrier |
US20020119635A1 (en) * | 2000-01-21 | 2002-08-29 | Bae Systems Information And Electronic Systems Integration, Inc. | Integrated resistor having aligned body and contact and method for forming the same |
US20030031698A1 (en) * | 2000-01-31 | 2003-02-13 | Roeder Ryan K. | Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods |
US20030021824A1 (en) * | 2000-03-01 | 2003-01-30 | Jean-Louis Lacout | Method for preparing a calcium phosphate pasty material for injection |
US20040031420A1 (en) * | 2000-07-13 | 2004-02-19 | Lin Jiin-Huey Chern | Calcium phosphate cement, use and preparation thereof |
US20030074081A1 (en) * | 2000-09-22 | 2003-04-17 | Ayers Reed A. | Non-uniform porosity tissue implant |
US6808561B2 (en) * | 2000-10-16 | 2004-10-26 | University Of South Carolina | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement |
US20020073894A1 (en) * | 2000-10-16 | 2002-06-20 | University Of South Carolina Research Foundation | Biocompatible cement containing reactive calcium phosphate nanoparticles and methods for making and using such cement |
US20030019396A1 (en) * | 2000-10-30 | 2003-01-30 | Howmedica Osteonics Corp. | Porous calcium phosphate cement |
US6547866B1 (en) * | 2000-10-30 | 2003-04-15 | Howmedica Osteonics Corp. | Porous calcium phosphate cement |
US20040185181A1 (en) * | 2000-12-07 | 2004-09-23 | Pentax Corporation | Porous sintered body of calcium phosphate-based ceramic and method for producing same |
US6752831B2 (en) * | 2000-12-08 | 2004-06-22 | Osteotech, Inc. | Biocompatible osteogenic band for repair of spinal disorders |
US20020137812A1 (en) * | 2001-01-24 | 2002-09-26 | American Dental Association Health Foundation | Premixed calcium phosphate cement pastes |
US6793725B2 (en) * | 2001-01-24 | 2004-09-21 | Ada Foundation | Premixed calcium phosphate cement pastes |
US20030055512A1 (en) * | 2001-05-21 | 2003-03-20 | Genin Francois Y. | Calcium based neutral and bioresorbable bone graft |
US20030078317A1 (en) * | 2001-08-30 | 2003-04-24 | Jiin-Huey Lin | Process for preparing a paste from calcium phosphate cement |
US6616742B2 (en) * | 2001-08-30 | 2003-09-09 | Cana Lab Corporation | Process for preparing a paste from calcium phosphate cement |
US20040022825A1 (en) * | 2001-12-21 | 2004-02-05 | Lagow Richard J. | Calcium phosphate bone replacement materials and methods of use thereof |
US20030120351A1 (en) * | 2001-12-21 | 2003-06-26 | Etex Corporation | Synthesis of calcium phosphates by mechano-chemical process |
US20030167093A1 (en) * | 2002-03-01 | 2003-09-04 | American Dental Association Health Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
US6955716B2 (en) * | 2002-03-01 | 2005-10-18 | American Dental Association Foundation | Self-hardening calcium phosphate materials with high resistance to fracture, controlled strength histories and tailored macropore formation rates |
US20040137032A1 (en) * | 2002-03-15 | 2004-07-15 | Wang Francis W. | Combinations of calcium phosphates, bone growth factors, and pore-forming additives as osteoconductive and osteoinductive composite bone grafts |
US20040076685A1 (en) * | 2002-07-11 | 2004-04-22 | Merck Patent Gmbh | Method of preparing porous calcium phosphate morsels and granules via gelatin processing |
US6929692B2 (en) * | 2002-08-27 | 2005-08-16 | Biomet Deutschland Gmbh | Calcium phosphate cement composition and a method for the preparation thereof |
US20040180091A1 (en) * | 2003-03-13 | 2004-09-16 | Chang-Yi Lin | Carbonated hydroxyapatite-based microspherical composites for biomedical uses |
US20040186481A1 (en) * | 2003-03-21 | 2004-09-23 | Cana Lab Corporation | Method for forming a hardened cement in a bone cavity |
US20050008759A1 (en) * | 2003-07-11 | 2005-01-13 | Li Nie | Grain protein-based formulations and methods of using same |
US20050101964A1 (en) * | 2003-11-07 | 2005-05-12 | Calcitec, Inc. | Spinal fusion procedure using an injectable bone substitute |
US20050184417A1 (en) * | 2004-02-19 | 2005-08-25 | Cana Lab Corporation | Method for making a porous calcium phosphate article |
US20050186354A1 (en) * | 2004-02-19 | 2005-08-25 | Lin Jiin-Huey C. | Method for making a porous calcium phosphate article |
US20050186449A1 (en) * | 2004-02-19 | 2005-08-25 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050268819A1 (en) * | 1999-07-14 | 2005-12-08 | Cana Lab Corporation | Injectable calcium phosphate cements and the preparation and use thereof |
US20060011099A1 (en) * | 1999-07-14 | 2006-01-19 | Lin Jiin-Huey C | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
US20060011100A1 (en) * | 1999-07-14 | 2006-01-19 | Lin Jiin-Huey C | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
US20050279256A1 (en) * | 1999-07-14 | 2005-12-22 | Lin Jiin-Huey C | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
US20050274289A1 (en) * | 1999-07-14 | 2005-12-15 | Lin Jiin-Huey C | Process for affecting the setting and working time of, bioresorbable calcium phosphate cements |
US20050274288A1 (en) * | 1999-07-14 | 2005-12-15 | Lin Jiin-Huey C | Process for affecting the setting and working time of bioresorbable calcium phosphate cements |
US20050279252A1 (en) * | 2000-07-13 | 2005-12-22 | Cana Lab Corporation | Tetracalcium phosphate (TTCP) with surface whiskers and method of making same |
US20050268820A1 (en) * | 2000-07-13 | 2005-12-08 | Calcitec, Inc. | Tetracalcium phosphate (TTCP) having calcium phosphate whisker on surface |
US20050271741A1 (en) * | 2000-07-13 | 2005-12-08 | Cana Lab Corporation | Injectable calcium phosphate cements and the preparation and use thereof |
US20050274287A1 (en) * | 2000-07-13 | 2005-12-15 | Lin Jiin-Huey C | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
US20050274286A1 (en) * | 2000-07-13 | 2005-12-15 | Lin Jiin-Huey C | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
US20050274282A1 (en) * | 2000-07-13 | 2005-12-15 | Lin Jiin-Huey C | Calcium phosphate cements made from (TTCP) with surface whiskers and process for preparing same |
US20030216777A1 (en) * | 2002-05-16 | 2003-11-20 | Yin-Chun Tien | Method of enhancing healing of interfacial gap between bone and tendon or ligament |
US20050184417A1 (en) * | 2004-02-19 | 2005-08-25 | Cana Lab Corporation | Method for making a porous calcium phosphate article |
US20050186449A1 (en) * | 2004-02-19 | 2005-08-25 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
US20050186354A1 (en) * | 2004-02-19 | 2005-08-25 | Lin Jiin-Huey C. | Method for making a porous calcium phosphate article |
US20050184418A1 (en) * | 2004-02-19 | 2005-08-25 | Calcitec, Inc. | Method for making a porous calcium phosphate article |
US20050263929A1 (en) * | 2004-05-25 | 2005-12-01 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
US20050263928A1 (en) * | 2004-05-25 | 2005-12-01 | Calcitec, Inc. | Dual function prosthetic bone implant and method for preparing the same |
US7754246B2 (en) | 2005-09-09 | 2010-07-13 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
US9180224B2 (en) | 2005-09-09 | 2015-11-10 | Agnovos Healthcare, Llc | Composite bone graft substitute cement and articles produced therefrom |
US8685465B2 (en) | 2005-09-09 | 2014-04-01 | Agnovos Healthcare, Llc | Composite bone graft substitute cement and articles produced therefrom |
US8685464B2 (en) | 2005-09-09 | 2014-04-01 | Agnovos Healthcare, Llc | Composite bone graft substitute cement and articles produced therefrom |
US8025903B2 (en) | 2005-09-09 | 2011-09-27 | Wright Medical Technology, Inc. | Composite bone graft substitute cement and articles produced therefrom |
EP2621869A2 (en) * | 2010-10-01 | 2013-08-07 | Skeletal Kinetics LLC | Porogen containing calcium phosphate cement compositions |
EP2621869A4 (en) * | 2010-10-01 | 2014-10-08 | Skeletal Kinetics Llc | Porogen containing calcium phosphate cement compositions |
CN102973983A (en) * | 2012-12-02 | 2013-03-20 | 复旦大学 | Water-soluble pore-foaming agent, porous scaffold and preparation method of porous scaffold |
CN102973983B (en) * | 2012-12-02 | 2015-01-07 | 复旦大学 | Water-soluble pore-foaming agent, porous scaffold and preparation method of porous scaffold |
US20160075599A1 (en) * | 2013-04-22 | 2016-03-17 | Mathys Ag Bettlach | Calcium phosphate cement composition |
US9611173B2 (en) * | 2013-04-22 | 2017-04-04 | Mathys Ag Bettlach | Calcium phosphate cement composition |
US9446170B2 (en) | 2013-12-13 | 2016-09-20 | Agnovos Healthcare, Llc | Multiphasic bone graft substitute material |
US10973949B2 (en) | 2013-12-13 | 2021-04-13 | Agnovos Healthcare, Llc | Multiphasic bone graft substitute material |
CN104098075A (en) * | 2014-06-19 | 2014-10-15 | 洛阳威乐美科技有限公司 | Preparation method of superfine calcium phosphate powder |
CN107106729A (en) * | 2014-11-17 | 2017-08-29 | 海洋纳米技术有限公司 | Bioactivity wound dressing and tooth coating based on the amorphous calcium polyphosphate with morphogenic activity |
Also Published As
Publication number | Publication date |
---|---|
US20050184418A1 (en) | 2005-08-25 |
US7083750B2 (en) | 2006-08-01 |
US20050186449A1 (en) | 2005-08-25 |
US7163651B2 (en) | 2007-01-16 |
US20050184417A1 (en) | 2005-08-25 |
US7119038B2 (en) | 2006-10-10 |
US7097793B2 (en) | 2006-08-29 |
US20050186354A1 (en) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7083750B2 (en) | Method for making a porous calcium phosphate article | |
US7118705B2 (en) | Method for making a molded calcium phosphate article | |
US7157027B2 (en) | Dual function prosthetic bone implant and method for preparing the same | |
US6616742B2 (en) | Process for preparing a paste from calcium phosphate cement | |
TWI275386B (en) | Methods for preparing medical implants from calcium phosphate cement and medical implants | |
CA2556901A1 (en) | Methods for preparing medical implants from calcium phosphate cement and medical implants | |
JP2001314497A (en) | Composition of matter for biomaterial and hardened body thereof | |
US20060173477A1 (en) | Dual function prosthetic bone implant and method for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20100801 |